Filing Details

Accession Number:
0001209191-23-025128
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-21 16:05:35
Reporting Period:
2023-04-19
Accepted Time:
2023-04-21 16:05:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1754068 Allovir Inc. ALVR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1337845 Vikas Sinha C/O Allovir, Inc.
1100 Winter Street
Waltham MA 02451
See Remarks Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-04-19 1,217 $3.71 1,186,521 No 4 S Direct
Common Stock Disposition 2023-04-20 1,466 $3.63 1,185,055 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 16,674,766 Indirect Shares held by ElevateBio LLC
Footnotes
  1. Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.64 to $3.84.Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.62 to $3.64.Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  4. Shares held by ElevateBio. The Reporting Person is a director and Chief Financial Officer of ElevateBio, and may be deemed to have sharedvoting and investment power of the shares held by ElevateBio. The Reporting Person disclaims beneficial ownership of these securities except tothe extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficialownership of all of the reported shares for purposes of Section 16 or for any other purpose.